Salix Pharmaceuticals, Inc. follows a competitive strategy of in-licensing late-stage products to treat GI diseases. Salix’s portfolio includes COLAZAL ®, XIFAXAN ®, VISICOL ®, AZASAN ®, ANUSOL-HC ®, PROCTOCORT ®, and IB-Stat ®. Exceptional customer service, a dedicated specialty sales force, and quality products highlight Salix’s commitment to the gastroenterology community.